Gang Wang
Director/Board Member bij SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
Actieve functies van Gang Wang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Director/Board Member | 20-10-2023 | - |
| Corporate Officer/Principal | 29-08-2019 | 20-10-2023 | |
| OBIO TECHNOLOGY (SHANGHAI) CORP., LTD. | Director/Board Member | 29-12-2020 | - |
| Independent Dir/Board Member | 29-12-2020 | - | |
Hrain Biotechnology Co., Ltd.
 Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Director/Board Member | 18-06-2021 | - |
| Independent Dir/Board Member | 18-06-2021 | - |
Loopbaan van Gang Wang
Opleiding van Gang Wang
| Dartmouth Medical School | Doctorate Degree |
Statistieken
Internationaal
| China | 4 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | Health Technology |
| OBIO TECHNOLOGY (SHANGHAI) CORP., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Health Technology |
